These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24168846)

  • 1. [Homocysteine levels: measure or not?].
    Smulders YM; den Heijer M; Blom HJ
    Ned Tijdschr Geneeskd; 2013; 157(44):A6265. PubMed ID: 24168846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The controversial role of B-vitamins in cardiovascular risk: An update.
    Ntaios G; Savopoulos C; Grekas D; Hatzitolios A
    Arch Cardiovasc Dis; 2009 Dec; 102(12):847-54. PubMed ID: 19963194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Homocysteine, folic acid, group B vitamins and cardiovascular risk].
    Blacher J; Czernichow S; Horrellou MH; Conad J; David P; Chadefaux-Vekemans B; Ankria A; Galan P; Hercberg S; Ducimetière P
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):145-52. PubMed ID: 15787307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate and homocysteine.
    Young IS; Woodside JV
    Curr Opin Clin Nutr Metab Care; 2000 Nov; 3(6):427-32. PubMed ID: 11085827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.
    Debreceni B; Debreceni L
    Cardiovasc Ther; 2014 Jun; 32(3):130-8. PubMed ID: 24571382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk.
    Spoelstra-de Man AM; Teerlink T; Brouwer CB; Rauwerda JA; Stehouwer CD; Smulders YM
    Clin Endocrinol (Oxf); 2006 May; 64(5):495-501. PubMed ID: 16649966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinaemia as a cardiovascular risk factor: an update.
    van der Griend R; Biesma DH; Banga JD
    Neth J Med; 2000 Mar; 56(3):119-30. PubMed ID: 10759023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild to moderate hyperhomocysteinaemia in cardiovascular disease.
    De Vriese AS; De Sutter JH; De Buyzere M; Duprez D
    Acta Cardiol; 1998; 53(6):337-44. PubMed ID: 10063428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina.
    Guo H; Chi J; Xing Y; Wang P
    Indian J Med Res; 2009 Mar; 129(3):279-84. PubMed ID: 19491420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.
    Selhub J; Jacques PF; Bostom AG; Wilson PW; Rosenberg IH
    Public Health Rev; 2000; 28(1-4):117-45. PubMed ID: 11411265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: effect on prognosis and possibilities of correction with drugs].
    Shakhmatova OO; Komarov AL; Panchenko EP
    Kardiologiia; 2010; 50(1):42-50. PubMed ID: 20144157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
    Cheng X
    Cardiovasc Ther; 2013 Aug; 31(4):e19-26. PubMed ID: 23082962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease?
    Abraham JM; Cho L
    Cleve Clin J Med; 2010 Dec; 77(12):911-8. PubMed ID: 21147945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and cardiovascular disease: a review of the evidence.
    Wierzbicki AS
    Diab Vasc Dis Res; 2007 Jun; 4(2):143-50. PubMed ID: 17654449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults.
    Carlsson CM
    Drugs Aging; 2006; 23(6):491-502. PubMed ID: 16872232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens.
    van der Griend R; Biesma DH; Banga JD
    Vasc Med; 2002 Feb; 7(1):29-33. PubMed ID: 12083731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine, B vitamins, and cardiovascular disease.
    de Craen AJ; Stott DJ; Westendorp RG
    N Engl J Med; 2006 Jul; 355(2):205-6; author reply 209-11. PubMed ID: 16837687
    [No Abstract]   [Full Text] [Related]  

  • 20. Homocysteine and arterial thrombosis: Challenge and opportunity.
    Di Minno MN; Tremoli E; Coppola A; Lupoli R; Di Minno G
    Thromb Haemost; 2010 May; 103(5):942-61. PubMed ID: 20352150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.